Background {#Sec1}
==========

Early recognition and accurate correction of tissue hypoperfusion are important in the treatment of shock. Central venous oxygen saturation (ScvO~2~), venous and arterial blood carbon dioxide partial pressure difference (Pv-aCO~2~), the venous--arterial blood carbon dioxide partial pressure difference/arterial-venous oxygen content difference ratio (Pv-aCO~2~/Ca-vO~2~) and lactate are important parameters employed during shock resuscitation \[[@CR1]\]. ScvO~2~ is associated with global tissue oxygenation, which can reflect the global balance between arterial O~2~ delivery and O~2~ consumption. If the value is low, anaerobic metabolism may arise. It was proved useful for hemodynamic management \[[@CR2]\], and was recommended as one of the early resuscitation goals in 2012 sepsis guidelines \[[@CR3]\]. Although ScvO~2~ was deleted in early resuscitation goals in 2016 sepsis guidelines \[[@CR4]\], it is still a useful clinical parameter. A ΔScvO~2~ threshold value of 5.0% discriminated fluid responders from non-responders with a sensitivity of 0.78 and specificity of 0.95 \[[@CR5]\]. Moreover, ScvO~2~ can also predict the success of spontaneous breathing trial \[[@CR6]\]. Pv-aCO~2~ is another alternative possible marker of tissue perfusion. According to the Fick equation, Pv-aCO~2~ is inversely related to cardiac output \[[@CR7]\]. A normal Pv-aCO~2~\<5 mmHg can be used as an adjunctive hemodynamic parameter to exclude tissue hypoperfusion in patients undergoing major surgery \[[@CR8]\]. Pv-aCO~2~ can also help clinicians make decisions of regarding the provision of therapy aimed at increasing cardiac output \[[@CR7]\]. The Pv-aCO~2~/Ca-vO~2~ ratio was shown to be a good indicator of anerobiosis assessed by hyperlactatemia. Mekontso-Dessap A et al. found that the Pv-aCO~2~/Ca-vO~2~ ratio (cut-off value ≥1.6) can detect global anaerobic metabolism in critically ill patients \[[@CR9]\]. The Pv-aCO~2~/Ca-vO~2~ ratio may provide useful information for assessing the lactate clearance potential and optimizing the lactate clearance rate \[[@CR10]\]. Moreover, the Pv-aCO~2~/Ca-vO~2~ ratio (cut-off value≥1.6) was an independent predictor of ICU mortality in septic shock patients with high ScvO~2~ after resuscitation \[[@CR11]\]. Increased serum lactate is an early indicator of septic shock and helps accomplish resuscitation goal, and it is recommended utilizing in sepsis guidelines \[[@CR3], [@CR4]\]. Given these four parameters above, and their values in shock resuscitation, some researchers have compiled them into a flow sheet to guide resuscitation therapy in septic shock \[[@CR1]\].

Before using a clinical parameter in therapeutic decisions, its accuracy is important. Unfortunately, previous studies have found that the values of arterial oxygen partial pressure (PaO~2~) and arterial carbon dioxide partial pressure (PaCO~2~) were influenced by time delay and sample storage temperature in blood gas analysis \[[@CR12], [@CR13]\]. The effects of time delay and body temperature on the measurements of ScvO~2~, Pv-aCO~2~, lactate and Pv-aCO~2~/Ca-vO~2~ have not been adequately studied. Thus, we designed this study to confirm the effects of time delay and body temperature on these four specific parameters.

Methods {#Sec2}
=======

The study was approved by the Ethics Committee of our hospital and registered at Chinese clinical trial registry (ChiCTR1800014484). It was performed from January 2018 to May 2018 in the intensive care unit of the affiliated hospital of Qingdao university. The patients with indwelling central venous and intra-arterial catheters were enrolled. Therefore, no additional invasive procedures were performed on patients merely to collect blood samples. Patients treated with antipyretic drugs or physical cooling were excluded.

A 2 mL sample of arterial blood was drawn from the indwelling intra-arterial catheter, and simultaneously, 2 mL venous blood sample was collected from the central venous catheter using plastic blood gas syringes (BD Preset™3ml, 22G × 1″, Becton, Dickinson and Company, United Kingdom) by a nurse. The nurse repeatedly drew blood in this manner for a total of 7 times, producing 7 sets of central venous and arterial blood samples simultaneously. Blood gas analysis was performed on one of the sets of the venous and arterial samples via blood gas analyzer (Radiometer ABL90 FLEX, Denmark) as soon as possible after sampling by another nurse. The time needed for transporting samples to the blood gas analyzer was less than 2 min for the first analysis. Then, blood gas analyses were repeated at 10, 20, 30, 40, 50 and 60 min after drawing for remaining 6 sets of samples. During the time delay, the blood samples were stored at 22 °C (room temperature). Pv-aCO~2~ and the Pv-aCO~2~/Ca-vO~2~ ratio were calculated \[[@CR11]\].

The patients' baseline data were also collected, such as age, gender, Acute Physiology and Chronic Health Evaluation (APACHE) II scores and primary diseases. Patients were divided into either the control group or the high temperature group according to whether their body temperature was greater than 38 °C. Body peripheral temperature was measured by mercury thermometer in axilla. Drawing blood gas samples and measuring body temperature were performed simultaneously.

Statistics analysis {#Sec3}
-------------------

The statistical analysis was performed using SPSS 22.0 software (SPSS, Inc., Chicago, IL, USA). The results were expressed as mean ± SD. Statistical analysis of the parameters over time was analyzed by repeated-measures ANOVA (analysis of variance). The statistical significance was set at *P* \<0.05.

Results {#Sec4}
=======

A total of 30 critically ill patients were enrolled. The baseline characteristics of them are shown in Tables [1](#Tab1){ref-type="table"} and [2](#Tab2){ref-type="table"}. There were no significant differences in baseline data between two groups (*P* \> 0.05).Table 1Baseline characteristics of patientsVariablesValueAge (years)63 ± 16Gender (male/female)19/11APACHE II scores21 ± 5Hemoglobin (g/L)96.3 ± 26.4White blood cells (10^9^/L)15.7 ± 11.2Primary diseases Pneumonia12 Abdominal infection8 Gastrointestinal hemorrhage5 Heart failure4 Bacterial liver abscess1Table 2Baseline characteristics of two groupsVariablesControl group (*n* = 19)High temperature group (*n* = 11)*P* valueAge (years)62 ± 1765 ± 130.704Gender (male/female)11/88/30.466APACHE II scores21 ± 620 ± 50.770Hemoglobin (g/L)91.9 ± 19.2103.9 ± 35.50.320White blood cells (10^9^/L)14.9 ± 8.517.2 ± 15.10.597Catecholamine therapy (yes/no)11/86/50.858Sepsis (yes/no)9/107/40.389Surgery (yes/no)10/94/70.389Trauma (yes/no)1/180/111.000PO~2~ baseline (mmHg)123 ± 106107 ± 340.551ScvO~2~ baseline (mmHg)67.7 ± 9.472.8 ± 7.70.140Patmospheric-vO~2~ baseline (mmHg)122.2 ± 5.9111.9 ± 5.80.084PvCO~2~ baseline (mmHg)47.7 ± 11.245.2 ± 11.30.413PaCO~2~ baseline (mmHg)42.6 ± 12.139.1 ± 10.10.435Pv-aCO~2~ baseline (mmHg)6.1 ± 2.56.0 ± 2.40.920Pv-aCO~2~/Ca-vO~2~ baseline1.7 ± 0.61.8 ± 0.50.626Lactate (mmol/L)1.4 ± 0.82.4 ± 2.10.149

There was a trend of increasing values for ScvO~2~, Pv-aCO~2~, Pv-aCO~2~/Ca-vO~2~ and lactate over time (*P* \< 0.001). ScvO~2~, Pv-aCO~2~/Ca-vO~2~ and lactate values of the samples stored for 10, 20, 30, 40, 50 and 60 min were significantly higher relative to baseline (*P* \< 0.05). There were no significant differences of PaCO~2~ and PvCO~2~ value over time (*P* \> 0.05). The values for Pv-aCO~2~ only increased after 40, 50 and 60 min compared to baseline (*P* \< 0.05), but there were no significant differences after 10, 20 or 30 min (Table [3](#Tab3){ref-type="table"}).Table 3Changes in values at different time pointsVariablesBaseline10 min20 min30 min40 min50 min60 minScvO~2~ (%)69.6 ± 9.071.8 ± 8.3^\*^73.8 ± 8.3^\*^75.9 ± 8.0^\*^77.5 ± 7.8^\*^79.6 ± 8.1^\*^81.7 ± 7.5^\*^PaCO~2~ (mmHg)41.4 ± 11.441.7 ± 11.342.2 ± 11.442.5 ± 11.442.9 ± 11.343.2 ± 11.243.6 ± 11.1PvCO~2~ (mmHg)47.4 ± 11.247.8 ± 10.948.3 ± 10.748.9 ± 10.749.4 ± 10.949.9 ± 10.750.3 ± 10.5Pv-aCO~2~ (mmHg)6.1 ± 2.46.1 ± 2.56.1 ± 2.56.3 ± 2.56.6 ± 2.6^\*^6.7 ± 2.8^\*^6.7 ± 2.9^\*^Pv-aCO~2~/Ca-vO~2~1.7 ± 0.61.9 ± 0.6^\*^2.1 ± 0.8^\*^2.6 ± 1.6^\*^3.0 ± 1.9^\*^3.3 ± 2.2^\*^4.0 ± 3.5^\*^Lactate (mmol/L)1.8 ± 1.51.9 ± 1.5^\*^2.1 ± 1.5^\*^2.2 ± 1.5^\*^2.3 ± 1.5^\*^2.4 ± 1.6^\*^2.6 ± 1.6^\*\*^significant difference compared to baseline (*P* \<0.05)

There was a trend of increasing ScvO~2~ differences, Pv-aCO~2~ differences, Pv-aCO~2~/Ca-vO~2~ differences and lactate differences between baseline and some point along storage time (*P* \< 0.05). The ScvO~2~ differences between baseline and after 10, 20, 30, 40, 50 and 60 min were all lower in the high temperature group than differences in the control group (*P* \< 0.05). The lactate differences between baseline and 20, 30, 40, 50 and 60 min were all slightly higher in the high temperature group than the differences in the control group (P \< 0.05). Pv-aCO~2~/Ca-vO~2~ ratio differences between baseline and 10 min were lower in the high temperature group than the ratio differences in the control group (*P* \< 0.05) (Table [4](#Tab4){ref-type="table"}).Table 4Comparisons of values between two groupsGroups10 min20 min30 min40 min50 min60 min△ScvO~2~ Control group (*n* = 19)2.8 ± 1.54.9 ± 1.67.2 ± 2.79.1 ± 3.211.4 ± 3.514.0 ± 4.4 High temperature group (*n* = 11)1.4 ± 0.93.2 ± 1.74.9 ± 1.86.1 ± 2.57.5 ± 3.48.9 ± 4.3 P value0.0130.0140.0160.0110.0060.005△Pv-aCO~2~ Control group (*n* = 19)0.1 ± 0.60.1 ± 1.00.3 ± 1.00.7 ± 0.80.7 ± 0.90.8 ± 1.1 High temperature group (*n* = 11)−0.2 ± 0.4−0.2 ± 0.90.2 ± 0.80.1 ± 1.00.4 ± 1.20.4 ± 1.4 P value0.1380.4690.6680.0540.4370.313△Pv-aCO~2~/ Ca-vO~2~ Control group (*n* = 19)0.23 ± 0.170.46 ± 0.491.1 ± 1.71.51 ± 1.941.89 ± 2.132.79 ± 3.85 High temperature group (*n* = 11)0.04 ± 0.160.25 ± 0.390.59 ± 0.630.77 ± 1.041.10 ± 1.301.41 ± 1.46 P value0.0050.2520.3740.2530.2790.264△Lactate Control group (*n* = 19)0.13 ± 0.080.23 ± 0.100.33 ± 0.120.43 ± 0.180.51 ± 0.190.62 ± 0.22 High temperature group (*n* = 11)0.16 ± 0.080.35 ± 0.140.51 ± 0.310.72 ± 0.440.89 ± 0.621.14 ± 0.80 P value0.3090.0120.0300.0150.0160.012*△ScvO*~*2*~ *x min* ScvO~2~ x min- ScvO~2~ baseline*△Pv-aCO*~*2*~ *x min* Pv-aCO~2~ x min- Pv-aCO~2~ baseline*△Pv-aCO*~*2*~*/ Ca-vO*~*2*~ *x min* Pv-aCO~2~/ Ca-vO~2~ x min- Pv-aCO~2~/ Ca-vO~2~ baseline*△Lactate x min* Lactate x min- Lactate baseline

Discussion {#Sec5}
==========

In this study, we found that there was a trend of increasing values for ScvO~2~, Pv-aCO~2~, Pv-aCO~2~/Ca-vO~2~ and lactate values with increased storage time. The differences in ScvO~2~, Pv-aCO~2~/Ca-vO~2~ and lactate between certain periods of storage time and baseline demonstrated differences between the high temperature group and the control group along certain points of storage time.

According to this study, we often over-estimated SvO~2~ levels of the central venous blood samples. The guideline of the American Association for Respiratory Care states that a delay in analysis of a venous blood gas of 30 min is acceptable \[[@CR14]\]. After a 30 min time delay in analysis, the ScvO~2~ increased approximately 6% in our study. This indicated that the guideline may lead to unsafe practices. The ScvO~2~ value was increasing over all storage times in the study, so we recommend blood gas samples be analyzed as soon as possible. It was proven that the PO~2~ of blood stored in a glass syringe decreases slightly over time, primarily as a result of continuing cellular metabolism \[[@CR13]\]. However, plastic syringes have supplanted glass syringes because of their convenience, low cost and breakage resistance. But plastic syringes, unlike glass syringes, are permeable to O~2~ \[[@CR15]\]. Atmospheric O~2~ has a partial pressure of 159 mmHg, well above venous blood O~2~. Therefore, O~2~ will permeate into plastic syringes until there is O~2~ partial pressure equilibration between the blood sample and the atmosphere. A previous study also indicated that the ScvO~2~ value increased over storage time \[[@CR16]\]. In this study, we found that the rate of ScvO~2~ change in patients with a temperature ≥ 38 °C was lower than patients with temperature\< 38 °C. The baseline ScvO~2~ values and atmospheric-venous blood O~2~ partial pressure difference between two groups displayed no difference. Therefore, the increasing O~2~ consumption may be explained the effects of temperature on ScvO~2~. We speculated that blood cells have an intrinsically hypermetabolic state in febrile patients and subsequently consumed more O~2~. Lactate is one of metabolites. The faster rising lactate in the high temperature group of this study may support the idea that blood cells in febrile patients had a high hypermetabolic state. Advanced cell experiments were needed to confirm the hypothesis. In previous studies, temperature correction of blood gas samples is not recommended \[[@CR14], [@CR17]\]. But according to our results, the effect of temperature on ScvO~2~ should not be ignored.

There were no significant differences of PaCO~2~ and PvCO~2~ value over time. The Pv-aCO~2~ increased only approximately 0.2 mmHg after a 30 min time delay in analysis, which may not have very important clinical implications. Furthermore, no effect of temperature on Pv-aCO~2~ was found. So there were few clinical effects of time delay and temperature on Pv-aCO~2~ value. In the calculation of Pv-aCO~2~/Ca-vO~2~ \[[@CR11]\], O~2~ partial pressure is an important parameter. Because of effects of the time delay on blood O~2~ partial pressure \[[@CR12], [@CR13]\], Pv-aCO~2~/Ca-vO~2~ may also be affected by time delay. In actuality, our results proved that this is the case. After a 30 min time delay, the ratio increased 1 by almost. Further, Pv-aCO~2~/Ca-vO~2~ difference was lower in patients in the high temperature group. At 10 min, the value demonstrated a significant difference. Lactate values were also affected by time delay and temperature, but the influence was not very strong. After a 30 min time delay, the lactate increased only approximately 0.4 mmol/L.

Conclusions {#Sec6}
===========

There were some influences of time delay or body temperature on ScvO~2~, Pv-aCO~2~, lactate and Pv-aCO~2~/Ca-vO~2~ values. We recommend that arterial and central venous blood gas samples be analyzed quickly within 10 min, especially for patients with body temperature \<38 °C.
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